Literature DB >> 2450887

Clonal analysis of functional differences among strains of human immunodeficiency virus (HIV).

S Harada1, N Yamamoto, Y Hinuma.   

Abstract

Different isolates (HTLV-IIIB, LAV1 and ARV2) of human immunodeficiency virus (HIV) were cloned by a plaque-forming assay using MT-4 cells. The reverse transcriptase (RT) activity and plaque-forming unit (PFU) titers of all viral preparations were assayed. PFU/RT values, which indicate the relative proportions of incomplete and infectious viruses, were used for determination of viral infectivity. High values were obtained mainly for clones of HTLV-IIIB and LAV1, and low values for ARV2-derived clones, suggesting that ARV2 and its clones were genetically less infectious. For studies on cytocidal effects of the viruses, four clones of HTLV-IIIB, LAV1 and ARV2 were selected that had similar PFU/RT (infectivity) values for proliferation in infected MT-4 cells. When compared at the same dose (MOI), one clone (HTLV-IIIB-C-2) was found to be more cytocidal than the others. Furthermore, plaques induced by HTLV-IIIB-C-2 were larger than those induced by other clones, suggesting that the release of progeny from HTLV-IIIB-C-2-infected cell and their proliferation were the most efficient. Among the cloned viruses tested, three were found to induce strong cytopathic changes (fusion and ballooning) selectively in MT-4 cells. Thus, the infectivity, proliferation and cytopathic fusion-effects were proposed to be encoded by the viral genome and be separable by the plaque-cloning method.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2450887     DOI: 10.1016/0166-0934(87)90090-5

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  3 in total

1.  The effect of bioreactor configuration on production of HIV and cell-virus interaction.

Authors:  J B Clarke; J B Griffiths
Journal:  Cytotechnology       Date:  1990-09       Impact factor: 2.058

2.  Generation and characterization of the human immunodeficiency virus type 1 mutants.

Authors:  A Adachi; N Ono; H Sakai; K Ogawa; R Shibata; T Kiyomasu; H Masuike; S Ueda
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

3.  Inhibition of human immunodeficiency virus replication in a human T cell line by antisense RNA expressed in the cell.

Authors:  J Gyotoku; M A el-Farrash; S Fujimoto; W T Germeraad; Y Watanabe; K Teshigawara; S Harada; Y Katsura
Journal:  Virus Genes       Date:  1991-07       Impact factor: 2.332

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.